{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:32:32Z","timestamp":1782325952261,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.juro.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T02:15:22Z","timestamp":1386641722000},"page":"1422-1428","source":"Crossref","is-referenced-by-count":29,"title":["Killed but Metabolically Active\n            <i>Mycobacterium bovis<\/i>\n            bacillus Calmette-Gu\u00e9rin Retains the Antitumor Ability of Live bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1097","volume":"191","author":[{"given":"Silvia","family":"Secanella-Fandos","sequence":"first","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Noguera-Ortega","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Olivares","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Luquin","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Juli\u00e1n","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.12.002_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/imt.10.32","article-title":"Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer","volume":"2","author":"Alexandroff","year":"2010","journal-title":"Immunotherapy"},{"issue":"suppl.","key":"10.1016\/j.juro.2013.12.002_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.eursup.2007.01.028","article-title":"The treatment of non\u2013muscle-invasive bladder cancer with intravesical chemotherapy and immunotherapy","volume":"6","author":"Whelan","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","article-title":"Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2013.12.002_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0022-5347(01)61832-9","article-title":"Effects of bacillus Calmette-Guerin and Interferon-a2b on cytokine production in human bladder cancer cell lines","volume":"161","author":"Zhang","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01517042","article-title":"Induction of bacillus-Calmette-Gu\u00e9rin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro","volume":"37","author":"Thanh\u00e4user","year":"1993","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2013.12.002_bib6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jnci\/52.5.1571","article-title":"Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets","volume":"52","author":"Zbar","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2013.12.002_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-4-86","article-title":"Immunodominant Pst1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer","volume":"4","author":"Sanger","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.juro.2013.12.002_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","article-title":"What are the immunologically active components of bacille Calmette-Gu\u00e9rin in therapy of superficial bladder cancer?","volume":"87","author":"Zlotta","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2013.12.002_bib9","first-page":"48","article-title":"Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results","volume":"134","author":"Kelley","year":"1985","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1442-2042.2002.00415.x","article-title":"Surface antigen expression on bladder tumor cells induced by\u00a0bacillus Calmette-Gu\u00e9rin (BCG): a role of BCG\u00a0internalization into tumor cells","volume":"9","author":"Ikeda","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.copbio.2012.04.005","article-title":"Killed but metabolically active vaccines","volume":"23","author":"Dubensky","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.juro.2013.12.002_bib12","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/IAI.00231-09","article-title":"Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice","volume":"77","author":"Magnani","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.juro.2013.12.002_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in\u00a0vitro among Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.juro.2013.12.002_bib14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1349-7006.2008.00832.x","article-title":"Activation of Toll-like receptor 2 by a\u00a0novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors","volume":"99","author":"Murata","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.juro.2013.12.002_bib15","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1128\/AEM.00457-08","article-title":"Inactivation of Mycobacterium avium complex by UV irradiation","volume":"74","author":"Shin","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.juro.2013.12.002_bib16","first-page":"285","article-title":"Evaluation of gamma radiation levels for reducing pathogenic bacteria and fungi in animal sewage and laboratory effluents","volume":"51","author":"Garcia","year":"1987","journal-title":"Can J Vat Res"},{"key":"10.1016\/j.juro.2013.12.002_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157340707781695550","article-title":"Recent advances in\u00a0methodologies for the discovery of antimycobacterial drugs","volume":"3","author":"Primm","year":"2007","journal-title":"Curr Bioact Compd"},{"key":"10.1016\/j.juro.2013.12.002_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mimet.2009.01.019","article-title":"Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105)","volume":"77","author":"Uenishi","year":"2009","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.juro.2013.12.002_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.juro.2012.09.049","article-title":"Connaught and Russian strains showed the highest direct antitumor effects of different bacillus Calmette-Gu\u00e9rin substrains","volume":"189","author":"Secanella-Fandos","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00262-009-0673-z","article-title":"Recombinant bacillus Calmette-Gu\u00e9rin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in\u00a0vitro","volume":"58","author":"Liu","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2013.12.002_bib21","first-page":"4089","article-title":"Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in\u00a0vitro","volume":"30","author":"Kato","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.juro.2013.12.002_bib22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","article-title":"Urinary interleukin-8 and 18 predict the response of\u00a0superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin","volume":"164","author":"Thalmann","year":"2000","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2013.12.002_bib23","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/314068","article-title":"In\u00a0vitro generation of bacillus Calmette-Gu\u00e9rin-activated killer cells","volume":"31","author":"Brandau","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2013.12.002_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2006.03191.x","article-title":"Role of Th1-stimulating cytokines in bacillus Calmette\u2013Gu\u00e9rin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells","volume":"146","author":"Luo","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.juro.2013.12.002_bib25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0022-5347(17)35941-4","article-title":"Dissecting the immunobiological effects of Bacillus Calmette-Gu\u00e9rin (BCG) in\u00a0vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon","volume":"150","author":"B\u00f6hle","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.2910130602","article-title":"Radiation-killed BCG in the treatment of transplanted rat tumors","volume":"13","author":"Baldwin","year":"1974","journal-title":"Intern J Cancer"},{"key":"10.1016\/j.juro.2013.12.002_bib27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/63.3.787","article-title":"Quantitative comparison of BCG strains and preparations in immunotherapy of a rat sarcoma","volume":"63","author":"Willmott","year":"1979","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2013.12.002_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/1097-0142(19800801)46:3<480::AID-CNCR2820460311>3.0.CO;2-C","article-title":"Immunotherapeutic effectiveness of BCG inactivated by various modalities","volume":"46","author":"Kreider","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2013.12.002_bib29","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0022-5347(05)69008-8","article-title":"Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49)","volume":"161","author":"G\u00fcnther","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.002_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.ju.0000091826.83705.79","article-title":"Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Gu\u00e9rin determine the succeeding Th1 response","volume":"170","author":"De Boer","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713060771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713060771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.12.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:28:54Z","timestamp":1651202934000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.12.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1016\/j.juro.2013.12.002"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.12.002","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}